Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.i.d. in asthma patients: a 12-week pilot study
Journal Title: Journal of Pulmonology and Respiratory Research - Year 2017, Vol 1, Issue 1
Abstract
Two of the most recent LABA/ICS combinations for treatment of persistent asthma are Fluticasone furoate/Vilanterol 92/22 µg (Ellipta) and Beclomethasone dipropionate/Formoterol 100/6 µg (Nexthaler).
Authors and Affiliations
Claudio Terzano, Francesca Oriolo
Keywords
Related Articles
- EP ID EP560445
- DOI 10.29328/journal.jprr.1001004
- Views 44
- Downloads 0
COPD and low plasma vitamin D levels: Correlation or causality?
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death and its prevalence and incidence is also related to smoking behavior [1]. COPD is still a chronic inflammatory and progressive disease caus...
Effect of diabetes mellitus on the Pulmonary Function Tests in Sudanese Diabetic Patients
Background: Diabetes mellitus is a leading cause of illness and death. Pulmonary function test PFT has assumed a key role in epidemiological studies investigating the incidence, natural history and causality of lung dise...
Peculiarities of photon emisson of whole non-diluted human blood obtained from healthy donors and patients with some diseases
Blood plays an important role in oxygen absorption and its transfer to organs and tissues in vertebrates, as well as in a number of invertebrate species. Numerous interactions between cellular and non-cellular blood comp...
A decade of targeted therapy for non-small cell lung cancer
Chemotherapy is one of the main treatment options for cancer. However, chemotherapeutic agents usually suffer from poor pharmaceutical properties that restrict their use. Targeted therapy drugs have been developed to spe...
Avoiding confusion in high flow oxygen therapy concepts
Oxygen therapy is the main supportive treatment in hypoxemic respiratory failure and has traditionally been delivered using low and high flow devices. However, the maximal flow rates that these devices can deliver are li...